Separately, Zacks Investment Research cut shares of Extraction Oil & Gas from a “buy” rating to a “hold” rating in a report on Friday, August 14th.
Shares of OTCMKTS:VVUSQ opened at $0.28 on Tuesday. Extraction Oil & Gas has a twelve month low of $0.07 and a twelve month high of $4.55. The company has a market capitalization of $6.61 million, a P/E ratio of -0.10 and a beta of -1.60.
VIVUS, Inc operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or high cholesterol.
Further Reading: What sectors are represented in the Nikkei Index?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Extraction Oil & Gas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extraction Oil & Gas and related companies with MarketBeat.com's FREE daily email newsletter.